Gajewski TF - Search Results

1

B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.

Liu X, Gao JX, Wen J, Yin L, Li O, Zuo T, Gajewski TF, Fu YX, Zheng P, Liu Y. Liu X, et al. Among authors: gajewski tf. J Exp Med. 2003 Jun 16;197(12):1721-30. doi: 10.1084/jem.20022089. J Exp Med. 2003. PMID: 12810690 Free PMC article.

2

B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.

Fallarino F, Fields PE, Gajewski TF. Fallarino F, et al. Among authors: gajewski tf. J Exp Med. 1998 Jul 6;188(1):205-10. doi: 10.1084/jem.188.1.205. J Exp Med. 1998. PMID: 9653097 Free PMC article.

3

Negative regulation of T-cell function by PD-1.

Zha Yy, Blank C, Gajewski TF. Zha Yy, et al. Among authors: gajewski tf. Crit Rev Immunol. 2004;24(4):229-37. doi: 10.1615/critrevimmunol.v24.i4.10. Crit Rev Immunol. 2004. PMID: 15588223 Review.

4

Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.

Yu P, Lee Y, Wang Y, Liu X, Auh S, Gajewski TF, Schreiber H, You Z, Kaynor C, Wang X, Fu YX. Yu P, et al. Among authors: gajewski tf. J Immunol. 2007 Aug 1;179(3):1960-8. doi: 10.4049/jimmunol.179.3.1960. J Immunol. 2007. PMID: 17641063 Free PMC article.

5

Costimulatory and coinhibitory receptors in anti-tumor immunity.

Driessens G, Kline J, Gajewski TF. Driessens G, et al. Among authors: gajewski tf. Immunol Rev. 2009 May;229(1):126-44. doi: 10.1111/j.1600-065X.2009.00771.x. Immunol Rev. 2009. PMID: 19426219 Free PMC article. Review.

6

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells.

Fuertes MB, Kacha AK, Kline J, Woo SR, Kranz DM, Murphy KM, Gajewski TF. Fuertes MB, et al. Among authors: gajewski tf. J Exp Med. 2011 Sep 26;208(10):2005-16. doi: 10.1084/jem.20101159. Epub 2011 Sep 19. J Exp Med. 2011. PMID: 21930765 Free PMC article.

7

Type I interferon response and innate immune sensing of cancer.

Fuertes MB, Woo SR, Burnett B, Fu YX, Gajewski TF. Fuertes MB, et al. Among authors: gajewski tf. Trends Immunol. 2013 Feb;34(2):67-73. doi: 10.1016/j.it.2012.10.004. Epub 2012 Oct 31. Trends Immunol. 2013. PMID: 23122052 Free PMC article. Review.

8

Innate and adaptive immune cells in the tumor microenvironment.

Gajewski TF, Schreiber H, Fu YX. Gajewski TF, et al. Nat Immunol. 2013 Oct;14(10):1014-22. doi: 10.1038/ni.2703. Nat Immunol. 2013. PMID: 24048123 Free PMC article. Review.

9

Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.

Yang X, Zhang X, Fu ML, Weichselbaum RR, Gajewski TF, Guo Y, Fu YX. Yang X, et al. Among authors: gajewski tf. Cancer Cell. 2014 Jan 13;25(1):37-48. doi: 10.1016/j.ccr.2013.12.004. Cancer Cell. 2014. PMID: 24434209 Free PMC article.

10

Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculature.

Spaapen RM, Leung MY, Fuertes MB, Kline JP, Zhang L, Zheng Y, Fu YX, Luo X, Cohen KS, Gajewski TF. Spaapen RM, et al. Among authors: gajewski tf. J Immunol. 2014 Oct 15;193(8):4254-60. doi: 10.4049/jimmunol.1401109. Epub 2014 Sep 12. J Immunol. 2014. PMID: 25217157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters